FiercePharma2d
In addressing inspection shortfall, FDA says it's gaining more inspectors than it's losing
In its effort to play catch up after thousands of factory inspections were delayed during the coronavirus pandemic, the FDA ...
The Miami Times11d
FDA has massive backlog of factory inspections
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in ...
Cherokee Phoenix8d
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in ...
MedPage Today17d
Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delays
Opens in a new tab or window An AP analysis of FDA data shows that agency staffers have not returned to roughly 2,000 pharmaceutical manufacturing firms to conduct surveillance inspections since ...
FDA’s inspections still lag pre-pandemic period
Under the FDA's own guidelines, factories that haven't been inspected in five or more years are considered a significant risk ...
ABC News17d
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
The firms that are overdue for safety and quality inspections represent about 42% of the 4,700 plants that are currently registered to produce drugs for the U.S. and previously underwent FDA ...
FiercePharma12d
FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections
Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered issues ...
FDA quietly launches safety review into IUD breakage amid our Paragard investigation
WASHINGTON — It's been three years since Spotlight on America started investigating reports of breakage and complications ...
Food Safety News9d
FDA tracking several outbreaks
The FDA continues to investigate six ongoing outbreaks from foodborne pathogens, with increasing patient counts in four of ...
Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds
The firms that are overdue for safety and quality inspections represent about 42% of the 4,700 plants that are currently ...
NBC Los Angeles17d
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U ...